Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Gilenya (fingolimod) - Important Safety Information from Novartis Ireland Ltd as approved by the HPRA (November 2017)
Notice type:
3rd Party Publications
Date:
07/11/2017
Problem Or Issue:
Important Safety Information communication from Novartis Ireland Ltd: Gilenya (fingolimod) - contraindications in patients with cardiac conditions.
Important Safety Information - Gilenya (fingolimod)
« Back
Date Printed: 23/04/2024